查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018711

輻射劑量監測市場：按產品類型、應用和最終用戶分類 - 2026-2032年全球市場預測

Radiation Dose Monitoring Market by Product Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，輻射劑量監測市場價值將達到 4.3044 億美元，到 2026 年將成長至 4.9046 億美元，到 2032 年將達到 11.5648 億美元，複合年成長率為 15.16%。

主要市場統計數據
基準年 2025 4.3044億美元
預計年份：2026年 4.9046億美元
預測年份 2032 1,156,480,000 美元
複合年成長率 (%) 15.16%

策略性實施，確立輻射劑量監測在臨床路徑、技術法規和病人安全優先事項的關鍵意義。

輻射劑量監測已從一項小眾的合規活動轉變為臨床品質、病人安全和企業數據策略的核心支柱。診斷影像的日益複雜、介入手術的激增以及監管力度的加強，使得即時和回顧性劑量資訊已成為必需品，而不再僅僅是可選項。臨床團隊現在期望整合的工作流程能夠提供情境化的劑量警報、自動文件記錄和分析回饋循環，以幫助最佳化各種檢查方式的方案。

人工智慧驅動的分析、雲端策略、更嚴格的監管以及以患者為中心的品質保證的需求，這些變革正在重新定義輻射劑量監測。

輻射劑量監測領域正經歷著一場變革，其驅動力包括技術的快速成熟、不斷變化的監管要求以及不斷湧現的臨床需求。人工智慧 (AI) 和機器學習正被整合到劑量分析中，從而實現異常值識別、方案偏差預測以及近乎即時的參數調整建議。因此，劑量監測解決方案正從被動的資料儲存庫演變為能夠影響臨床操作人員行為和方案選擇的主動決策工具。

評估 2025 年美國關稅變化對全球供應鏈採購韌性和劑量監測臨床技術部署的累積影響。

2025年實施的關稅措施對輻射劑量監測技術領域的製造商、經銷商和醫療保健機構產生了複雜而深遠的後續影響。供應商正在調整採購、零件替代和物流策略，以應對成本壓力並維持生產連續性，供應鏈的韌性正面臨考驗。對於許多企業而言，供應商多元化和探索近岸外包變得越來越重要，因為依賴單一來源的零件會加劇其對貿易政策變化的脆弱性。

清晰的細分市場分析：展示產品類型、臨床應用和最終用戶特徵如何決定採購行為、部署管道和服務期望。

對市場區隔的精準理解揭示了每種產品類型、臨床應用和最終用戶環境的不同需求，這有助於產品設計和商業化策略的發展。就產品類型而言，市場可分為設備與服務兩大類。設備客戶會根據處理能力、空間限制和所執行手術的配置來權衡固定式設備和可攜式之間的優缺點。而服務客戶則會在持續維護合約（以確保運轉率和符合法規要求）與諮詢專業知識之間進行權衡。

區域趨勢：本節闡明了推動劑量監測技術、報銷途徑和採用模式的因素在美洲、歐洲、中東和非洲以及亞太地區有何不同。

區域趨勢對輻射劑量監測技術的應用和實施有顯著影響，各主要區域之間存在顯著差異。在美洲，法律規範和報銷環境推動了集中式分析與現場最佳化相結合的發展，醫療系統也經常尋求能夠跨醫院網路擴展的企業級部署方案。這催生了對能夠提供多站點管治、標準化報告以及與現有電子健康記錄和品質註冊系統整合的解決方案的需求。

企業策略和競爭動態塑造了輻射劑量監測整個價值鏈中的創新夥伴關係、服務模式和監管合規性。

劑量監測生態系中的企業行為呈現產品創新、策略夥伴關係與服務多元化融合的趨勢。領先的供應商意識到，分析、報告和生命週期服務正日益成為衡量客戶價值的關鍵因素，因此正加大對軟體能力的投入，以完善其硬體產品組合。與臨床網路、學術機構和第三方分析提供者建立夥伴關係十分普遍，這有助於加速檢驗、擴展基準測試資料集，並共同開發整合到工作流程中的決策支援模組。

為產業領導者提供切實可行的建議，以加快劑量監測投資的採用、加強合規性並從中提取臨床營運價值。

致力於加速劑量監測技術應用並提升其有效性的行業領導者應立即採取謹慎措施，確保技術選擇與臨床和營運重點保持一致。首先，投資於支援標準化資料交換並與電子健康記錄和影像系統無縫整合的互通平台。這將減少工作流程中的摩擦，並改善企業管治。其次，優先考慮模組化架構和軟體定義功能，以實現分階段升級，並減少對可能中斷營運的大規模設備更換週期的依賴。

調查方法，描述了一種嚴格的混合方法，結合了相關人員訪談、設備審核、監管審查和技術檢驗協議。

嚴謹的混合方法研究途徑是獲取輻射劑量監測可靠見解的基礎，它將與相關人員的定性對話與技術和法規分析相結合。主要資訊來源包括對臨床負責人、醫學物理學家、放射技師和採購負責人的結構化訪談，透過這些訪談了解實際操作、實施障礙和理想解決方案的特徵。除了這些對話之外，還進行儀器和工作流程審核，以觀察資料收集點、整合點以及方案協調的機會。

結論：本報告整合了策略性關鍵要點和可操作的見解，旨在幫助相關人員提高病患安全、工作流程效率和技術整合水準。

技術、臨床和商業性觀點的整合凸顯了一個明確的需求：輻射劑量監測必須從孤立的合規機制轉變為支持更安全、更有效率醫療保健的綜合臨床智慧。儘管分析技術和雲端基礎設施的進步使這一轉變成為可能，但其成功取決於對互通性、管治和證據生成的認真考慮。優先考慮模組化架構、靈活經營模式和穩健服務夥伴關係關係的組織將更有能力長期維持其能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 輻射劑量監測市場：依產品類型分類

  • 裝置
    • 固定設備
    • 攜帶式設備
  • 服務
    • 諮詢服務
    • 維護服務

第9章：輻射劑量監測市場：依應用領域分類

  • 診斷影像
    • 電腦斷層掃描
    • 磁振造影
    • 超音波
    • X光
  • 介入放射學
    • 心臟介入
    • 介入神經放射學
    • 血管介入
  • 核子醫學
    • 正子斷層掃描
    • 單光子發射電腦斷層掃描
  • 放射治療
    • 近距離放射治療
    • 遠距放射線治療

第10章 輻射劑量監測市場：依最終用戶分類

  • 學術機構
  • 診所
  • 診斷中心
  • 醫院

第11章：輻射劑量監測市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：輻射劑量監測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：輻射劑量監測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國輻射劑量監測市場

第15章：中國輻射劑量監測市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group NV
  • Bayer AG
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • Fluke Biomedical
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Guerbet SA
  • Koninklijke Philips NV
  • Landauer, Inc.
  • Ludlum Measurements, Inc.
  • Medtronic plc
  • Mirion Technologies, Inc.
  • Novarad Corporation
  • PACSHealth, LLC
  • Qaelum NV
  • Radiation Detection Company（RADEC）
  • Sectra AB
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Unfors Raysafe AB
Product Code: MRR-AD36CD8983FB

The Radiation Dose Monitoring Market was valued at USD 430.44 million in 2025 and is projected to grow to USD 490.46 million in 2026, with a CAGR of 15.16%, reaching USD 1,156.48 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 430.44 million
Estimated Year [2026] USD 490.46 million
Forecast Year [2032] USD 1,156.48 million
CAGR (%) 15.16%

A strategic introduction establishing the critical importance of radiation dose monitoring across clinical pathways technology regulations and patient safety priorities

Radiation dose monitoring has moved from a niche compliance activity into a central pillar of clinical quality, patient safety, and enterprise data strategy. Advances in imaging complexity, the proliferation of interventional procedures, and heightened regulatory scrutiny have combined to make real-time and retrospective dose intelligence an operational necessity rather than an optional capability. Clinical teams now expect integrated workflows that provide context-sensitive dose alerts, automated documentation, and analytic feedback loops that inform protocol optimization across modalities.

In parallel, health systems and diagnostic service providers are prioritizing technologies that reduce variability, document regulatory adherence, and support value-based care imperatives. This has elevated expectations for interoperability, as dose monitoring must exchange structured information with electronic medical records, picture archiving and communication systems, and quality registries. Consequently, decisions about procurement, deployment, and service models are increasingly influenced by factors beyond raw device performance; considerations such as software lifecycle management, data governance, and vendor support frameworks are now central to adoption discussions.

Taken together, these forces are reshaping the conversation about dose monitoring: stakeholders demand systems that are not only accurate and reliable, but also demonstrably sustainable within constrained capital and operational budgets. For clinical leaders and technology planners, the imperative is to evaluate capabilities through the lenses of clinical impact, workflow integration, and long-term maintainability, ensuring that investments deliver measurable improvements in safety and efficiency.

Transformational shifts redefining radiation dose monitoring through AI enabled analytics cloud strategies regulatory tightening and patient centric quality imperatives

The landscape of radiation dose monitoring is undergoing transformative shifts driven by rapid technological maturation, shifting regulatory expectations, and new clinical imperatives. Artificial intelligence and machine learning are being embedded into dose analytics to identify outliers, predict protocol deviations, and recommend parameter adjustments in near real time. As a result, dose monitoring solutions are evolving from passive repositories into active decision-support tools that can influence operator behavior and protocol selection at the point of care.

Concurrently, cloud-native architectures and federated data approaches are enabling broader aggregation and benchmarking of dose metrics across facilities while preserving data privacy. This shift toward centralized analytics paired with distributed collection points permits longitudinal analyses that were previously impractical, and it supports enterprise-level governance and continuous improvement programs. Moreover, there is a discernible move toward modular, API-driven ecosystems that favor interoperability and incremental modernization rather than wholesale equipment replacement.

On the regulatory front, agencies are emphasizing traceability, documentation, and patient communication, which compels organizations to embed dose monitoring into clinical quality frameworks. Patient expectations are also changing: informed patients and referring clinicians increasingly request transparency about radiation exposure and comparative safety profiles. Taken together, these trends create an environment where technological innovation, data architecture, and regulatory compliance intersect to drive widespread adoption and more sophisticated use cases for dose monitoring technologies.

Assessing cumulative effects of 2025 United States tariff shifts on global supply chains procurement resilience and clinical technology adoption for dose monitoring

Tariff measures enacted in 2025 have created a complex set of downstream implications for manufacturers, distributors, and healthcare providers involved in radiation dose monitoring technologies. Supply chain elasticity has been tested as vendors adapt sourcing, component substitution, and logistics strategies to maintain manufacturing continuity while managing cost pressures. For many organizations this has elevated the importance of supplier diversification and nearshoring considerations, as reliance on single-source components can amplify vulnerability to trade policy volatility.

Procurement teams and clinical technology planners are responding by reassessing total cost of ownership and service models, with a stronger focus on maintenance contracts, spare-part availability, and remote service capabilities that can mitigate on-site constraints. In addition, extended lead times for certain components have accelerated the adoption of software-centric solutions and retrofit pathways that reduce dependence on new hardware procurement. Consequently, organizations are prioritizing interoperability and upgradeability to maximize lifespan and functional value of installed systems.

As stakeholders adapt, transparency and scenario planning have become important governance practices. Health systems are instituting contingency protocols and stock management approaches to preserve clinical continuity. Vendors that demonstrate resilient supply strategies, clear aftermarket support, and options for phased upgrades are gaining higher consideration in procurement processes. Ultimately, the tariff environment in 2025 has underscored the strategic value of flexible acquisition models and durable service partnerships for sustaining dose monitoring capabilities under shifting trade dynamics.

Segment driven clarity demonstrating how product types clinical applications and end-user characteristics determine procurement behaviors adoption pathways and service expectations

A nuanced understanding of market segments uncovers differentiated needs across product types, clinical applications, and end-user settings, which in turn informs product design and commercialization strategies. When considering product types, the landscape bifurcates into equipment and services. Equipment customers evaluate trade-offs between fixed installations and portable units based on throughput, space constraints, and procedure mix, while services customers weigh consulting expertise against ongoing maintenance commitments that sustain uptime and regulatory compliance.

Application-driven demand reflects modality-specific requirements and clinical complexity. Diagnostic imaging use cases span computed tomography, magnetic resonance imaging, ultrasound, and conventional X-ray, each presenting unique dose measurement, tracking, and reporting challenges. Interventional radiology brings distinct imperatives across cardiac, neuro, and vascular interventions where fluoroscopy time and cumulative exposure must be managed dynamically. Nuclear medicine workflows involving positron emission tomography and single photon emission computed tomography demand specialized dosimetry considerations, and radiotherapy applications such as brachytherapy and external beam treatments require tightly integrated dose verification and documentation protocols.

End-user profiles-academic institutes, clinics, diagnostic centers, and hospitals-shape procurement behavior, budget cycles, and support expectations. Academic centers tend to emphasize research extensibility and analytics sophistication, while clinics and diagnostic centers prioritize compact footprint and streamlined workflows. Hospitals demand enterprise-class interoperability, robust service guarantees, and scalable governance mechanisms. Recognizing these distinctions enables product roadmaps and commercial approaches to be tailored to the operational realities of each segment, thereby improving adoption likelihood and clinical impact.

Regional dynamics revealing how Americas Europe Middle East & Africa and Asia-Pacific diverge in adoption drivers reimbursement pathways and deployment models for dose monitoring

Regional dynamics exert powerful influence over how radiation dose monitoring technologies are adopted and implemented, with notable contrasts across major geographies. In the Americas, regulatory frameworks and reimbursement environments encourage a combination of centralized analytics and site-level optimizations, and health systems frequently pursue enterprise deployments that can scale across hospital networks. This creates demand for solutions that offer multi-site governance, standardized reporting, and integration with existing electronic health records and quality registries.

Europe, Middle East & Africa exhibits considerable heterogeneity driven by divergent regulatory regimes, infrastructure maturity, and public versus private care models. In some parts, stringent regulatory expectations and active professional societies have accelerated the adoption of dose monitoring programs, whereas in other areas resource constraints necessitate more pragmatic and phased approaches. Interoperability standards and data protection rules are central considerations, often prompting investments in secure architectures and localized data management strategies.

The Asia-Pacific region demonstrates a mix of rapid technology adoption in urban tertiary centers and pragmatic solutions for community facilities. High-volume imaging centers and leading hospitals often act as early adopters of advanced analytics and integrated dose governance, while broader system-level initiatives are gradually extending capabilities to regional facilities. Across all regions, localized regulatory nuance, capital planning cycles, and workforce availability shape deployment choices and service models, making regional strategy an essential component of any commercialization plan.

Corporate strategies and competitive dynamics shaping innovation partnerships service models and regulatory alignment across the radiation dose monitoring value chain

Corporate behavior in the dose monitoring ecosystem is characterized by a blend of product innovation, strategic partnerships, and service diversification. Leading vendors are investing in software capabilities that complement their hardware portfolios, recognizing that analytics, reporting, and lifecycle services increasingly define customer value. Partnerships with clinical networks, academic centers, and third-party analytics providers are common, enabling accelerated validation, expanded data sets for benchmarking, and co-development of workflow-embedded decision-support modules.

Commercial strategies emphasize flexible contracting and outcome-oriented services to align with customers' fiscal constraints and quality objectives. Many companies are experimenting with subscription models, managed services, and hybrid arrangements that combine capital equipment with enduring service commitments. In parallel, investments in customer success functions and remote diagnostics have become critical differentiators, as institutions value predictable uptime and proactive maintenance that minimize clinical disruption.

Regulatory diligence and standards alignment also shape corporate strategies. Vendors that demonstrate robust compliance frameworks, clear audit trails, and interoperability with mainstream health IT systems gain higher trust among procurement committees. Finally, companies that prioritize transparent evidence generation-through peer-reviewed studies, real-world performance data, and clinician endorsements-are better positioned to influence clinical guidelines and accelerate adoption across diverse healthcare settings.

Actionable recommendations for industry leaders to accelerate adoption strengthen compliance and extract clinical operational value from dose monitoring investments

Industry leaders seeking to accelerate the adoption and impact of dose monitoring should take immediate and deliberate steps to align technology choices with clinical and operational priorities. First, invest in interoperable platforms that support standardized data exchange and integrate seamlessly with electronic health records and imaging systems; this reduces workflow friction and facilitates enterprise governance. Second, prioritize modular architectures and software-defined capabilities that enable incremental upgrades and reduce dependence on disruptive capital refresh cycles.

Organizations should also formalize governance processes that link dose metrics to clinical quality programs, ensuring responsibility for monitoring, escalation, and continuous improvement. Training and change management are essential components: empowering technologists and physicians with contextualized feedback and clear escalation pathways drives behavioral change more effectively than standalone alerts. From a commercial standpoint, adopt flexible procurement structures such as outcome-based agreements or managed services to align incentives between vendors and providers.

Finally, develop a roadmap for evidence generation that includes local validation studies, peer-reviewed publications, and cross-site benchmarking. Demonstrating clinical and operational benefits builds stakeholder confidence and supports broader rollouts. By combining robust technical foundations with disciplined governance and stakeholder engagement, leaders can convert dose monitoring from a compliance item into a sustainable driver of patient safety and operational efficiency.

Research methodology describing a rigorous mixed methods approach that combines stakeholder interviews device audits regulatory review and technology validation protocols

A rigorous mixed-methods research approach underpins credible insights into radiation dose monitoring, blending qualitative stakeholder engagement with technical and regulatory analyses. Primary inputs include structured interviews with clinical leaders, medical physicists, radiology technologists, and procurement officers to capture operational realities, adoption barriers, and desired solution attributes. These conversations are complemented by device and workflow audits that observe data capture points, integration touchpoints, and opportunities for protocol harmonization.

Secondary analysis involves a careful review of regulatory guidance, clinical practice recommendations, and standards for dosimetry and reporting to ensure interpretations reflect current obligations and best practices. Technology verification protocols assess interoperability, data fidelity, and analytic reproducibility under representative clinical conditions. Where possible, cross-site comparisons of implementation pathways and service models are synthesized to surface replicable practices and common pitfalls.

Throughout the process, data governance and ethical considerations guide the collection and use of sensitive clinical information, with anonymization and secure handling protocols applied consistently. Triangulating qualitative insights with technical validation and regulatory context provides a multidimensional view of both the opportunities and constraints facing dose monitoring initiatives.

Conclusion synthesizing strategic takeaways and practical implications for stakeholders aiming to enhance patient safety workflow efficiency and technology integration

The synthesis of technical, clinical, and commercial perspectives reveals a clear imperative: radiation dose monitoring must evolve from isolated compliance mechanisms into integrated clinical intelligence that supports safer, more efficient care. Technological advances in analytics and cloud infrastructure make this transition feasible, yet success depends on deliberate attention to interoperability, governance, and evidence generation. Organizations that prioritize modular architectures, flexible commercial models, and robust service partnerships will be better equipped to sustain capability over time.

Moreover, regional and procurement pressures have underscored the importance of resilient supply strategies and lifecycle planning. Adopting retrofit and software-first pathways can preserve clinical capability while mitigating capital and supply chain risks. Finally, the most impactful implementations are those that align technical functionality with clinician workflows and organizational quality objectives, thereby converting dose monitoring into a measurable contributor to patient safety and operational improvement.

In short, the opportunity lies not merely in deploying new tools but in embedding them into continuous improvement systems that drive accountable, evidence-based change across imaging and interventional services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Dose Monitoring Market, by Product Type

  • 8.1. Equipment
    • 8.1.1. Fixed Equipment
    • 8.1.2. Portable Equipment
  • 8.2. Services
    • 8.2.1. Consulting Services
    • 8.2.2. Maintenance Services

9. Radiation Dose Monitoring Market, by Application

  • 9.1. Diagnostic Imaging
    • 9.1.1. Computed Tomography
    • 9.1.2. Magnetic Resonance Imaging
    • 9.1.3. Ultrasound
    • 9.1.4. X Ray
  • 9.2. Interventional Radiology
    • 9.2.1. Cardiac Intervention
    • 9.2.2. Neuro Intervention
    • 9.2.3. Vascular Intervention
  • 9.3. Nuclear Medicine
    • 9.3.1. Positron Emission Tomography
    • 9.3.2. Single Photon Emission Computed Tomography
  • 9.4. Radiotherapy
    • 9.4.1. Brachytherapy
    • 9.4.2. External Beam Radiotherapy

10. Radiation Dose Monitoring Market, by End User

  • 10.1. Academic Institutes
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals

11. Radiation Dose Monitoring Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Radiation Dose Monitoring Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Radiation Dose Monitoring Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Radiation Dose Monitoring Market

15. China Radiation Dose Monitoring Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Agfa-Gevaert Group NV
  • 16.6. Bayer AG
  • 16.7. Bracco Imaging S.p.A.
  • 16.8. Canon Medical Systems Corporation
  • 16.9. Fluke Biomedical
  • 16.10. FUJIFILM Holdings Corporation
  • 16.11. GE HealthCare Technologies Inc.
  • 16.12. Guerbet SA
  • 16.13. Koninklijke Philips N.V.
  • 16.14. Landauer, Inc.
  • 16.15. Ludlum Measurements, Inc.
  • 16.16. Medtronic plc
  • 16.17. Mirion Technologies, Inc.
  • 16.18. Novarad Corporation
  • 16.19. PACSHealth, LLC
  • 16.20. Qaelum NV
  • 16.21. Radiation Detection Company (RADEC)
  • 16.22. Sectra AB
  • 16.23. Siemens Healthineers AG
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Unfors Raysafe AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION DOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIATION DOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY FIXED EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY FIXED EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY FIXED EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PORTABLE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PORTABLE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PORTABLE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CARDIAC INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CARDIAC INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CARDIAC INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 181. GCC RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 211. G7 RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. G7 RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 221. NATO RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 222. NATO RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)